Bioxytran (BIXT) Net Margin Growth (1y) (2011 - 2018)
Bioxytran (BIXT) Net Margin Growth (1y) (2011 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.79 Bn | 131.94 Bn | 2.84 Bn | -185.00 |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.74 Bn | 3.93 Bn | -763.00 |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn | 529.00 |
| 4 | Moderna | 59.32 Bn | 54.18 Bn | 52.00 Mn | 4,168.00 |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 673.00 |
| 6 | Alnylam Pharmaceuticals | 31.81 Bn | 28.50 Bn | 992.69 Mn | 2,208.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -1,652.00 |
| 8 | Insmed | 27.56 Bn | 26.40 Bn | 358.27 Mn | 29,636.00 |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | -392.00 |
| 10 | Bioxytran | 2.52 Mn | 2.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 65,840.00 |
| Mar 31, 2018 | 64,617.00 |
| Dec 31, 2017 | -50,226.00 |
| Sep 30, 2017 | 25,697.00 |
| Jun 30, 2017 | -39,851.00 |
| Mar 31, 2017 | 57,487.00 |
| Dec 31, 2016 | 21,685.00 |
| Sep 30, 2016 | -39,776.00 |
| Jun 30, 2016 | 296,436.00 |
| Mar 31, 2016 | -138,093.00 |
| Dec 31, 2015 | -193,027.00 |
| Sep 30, 2015 | 287,610.00 |
| Jun 30, 2015 | -307,193.00 |
| Mar 31, 2015 | -9,263.00 |
| Dec 31, 2014 | 200,930.00 |
| Sep 30, 2014 | -219,223.00 |
| Jun 30, 2014 | 49,245.00 |
| Mar 31, 2014 | 88,233.00 |
| Dec 31, 2013 | 106,200.00 |
| Sep 30, 2013 | 441,190.00 |